Phase 3 Trial of Crinecerfont in Pediatric Congenital Adrenal Hyperplasia.
Sarafoglou K, Kim MS, Lodish M, Felner EI, Martinerie L, Nokoff NJ, Clemente M, Fechner PY, Vogiatzi MG, Speiser PW, Auchus RJ, Rosales GBG, Roberts E, Jeha GS, Farber RH, Chan JL; CAHtalyst Pediatric Trial Investigators.
Sarafoglou K, et al. Among authors: kim ms.
N Engl J Med. 2024 Jun 2. doi: 10.1056/NEJMoa2404655. Online ahead of print.
N Engl J Med. 2024.
PMID: 38828945